Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04601233 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

StatusWithdrawn
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Withdrawn before enrolling Sponsor's reason: The study didn't receive funding to move forward.
    • Primary and study completion dates changed from estimate of Dec 2026 to Sep 30, 2026
  2. Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: The study didn't receive funding to move forward. Show 5 more changesShow less
    • Enrollment target: estimated 20 to confirmed 0
    • Eligibility criteria expanded, about 27 words
    • Secondary endpoints: details revised at 2 of 11 entries
    • Site contact updated
    • Publications: details revised at 6 of 6 entries
  3. Primary and study completion dates: Dec 2025 to Dec 2026
    • Start date: Jun 2025 to Jun 2026
    v11
  4. Primary and study completion dates: Dec 2024 to Dec 2025
    • Start date: Jun 2024 to Jun 2025
    v10
  5. Start date: Dec 2023 to Jun 2024
    • Primary and study completion dates: Aug 2024 to Dec 2024
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary and study completion dates: Aug 31, 2023 to Aug 2024
    • Start date: Dec 2022 to Dec 2023
    v8
  2. Primary and study completion dates: Aug 31, 2022 to Aug 31, 2023
    • Start date: Dec 2021 to Dec 2022
    v7
  3. Primary and study completion dates: Jan 31, 2022 to Aug 31, 2022
    • Start date: Aug 2021 to Dec 2021
    v6
  4. Start date: May 2021 to Aug 2021v5
  5. Start date: Mar 1, 2021 to May 2021v4
  6. Start date: Jan 4, 2021 to Mar 1, 2021v3
  7. Start date: Nov 1, 2020 to Jan 4, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to determine the effects of testosterone treatment on erectile function, fatigue, depression, cognitive function, quality of life, urinary incontinence, pain, and damage to neurons in male Multiple Sclerosis patients with low testosterone, using questionnaires, blood samples and a rectal exam in volunteers 55 years and older.
Trial Details
NCT Number NCT04601233
Lead Sponsor Tulane University
Collaborators: Louisiana State University Health Sciences Center in New Orleans, Antares Pharma Inc.
Conditions
(from sponsor)		 Multiple Sclerosis, Erectile Dysfunction, Testosterone Deficiency
Related terms Erectile Dysfunction, Multiple Sclerosis
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov